You are here

Evidence-Based Resource Summary

Strength of Evidence: 
4 out of 4
4 out of 4
Year Published: 
2014

Aspirin to Prevent Morbidity and Mortality From Preeclampsia: Preventive Medication in Pregnant Women

Description of Resource: 
The U.S. Preventive Services Task Force (USPSTF) recommends the use of low-dose aspirin (81 mg/d) as preventive medication after 12 weeks of gestation in women who are at high risk for preeclampsia. This is a B recommendation, which means the USPSTF recommends the service. There is high certainty that the net benefit is moderate or there is moderate certainty that the net benefit is moderate to substantial.

Evidence-Based Resource Details

help Learn more about EBR criteria
Developed By: 
United States Preventive Services Task Force
Developer Type: 
Federal Government
Healthy People 2020 Topic Area(s): 
Heart Disease and Stroke
Healthy People 2020 Objectives: 
Resource Type: 
Systematic Review
Citation: 
U.S. Preventive Services Task Force. Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia [Internet]. 2014 Sept [cited 2017 Sept 8]. Available from: https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication?ds=1&s=Aspirin%20to%20Prevent%20Morbidity%20and%20Mortality%20From%20Preeclampsia